TRAX

First Tracks Biotherapeutics Inc NASDAQ Listed Apr 20, 2026

Healthcare ·Biotechnology ·US

$17.78

After hrs $17.10 -12.49%

Mkt Cap $617.8M

52w Low $14.79 24.9% of range 52w High $26.80

50d MA $21.33 200d MA $21.33

P/E (TTM) —

EV/EBITDA —

P/B —

Debt/Equity —

ROE —

P/FCF —

RSI (14) —

ATR (14) —

Beta 0.00

50d MA $21.33

200d MA $21.33

Avg Volume 293.0K

First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.

SIC Code

2834

CIK (SEC)

2091349

Phone

212-373-3000

10770 WATERIDGE CIRCLE · San Diego, CA 92121 · US

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 4	Piper Sandler	Initiates	Overweight	$54	$22.38	$21.52	-3.8%	-8.2%	-5.3%	-9.5%	-20.4%	—
Apr 28	H.C. Wainwright	Initiates	Buy	$30	$18.10	$17.44	-3.6%	+10.8%	+30.6%	+28.6%	+23.6%	+13.5%
Apr 24	Leerink Partners	Initiates	Outperform	$46	$19.00	$20.20	+6.3%	-4.4%	-4.7%	+5.5%	+24.4%	+22.5%
Apr 24	Wedbush	Initiates	Outperform	$30	$19.00	$20.20	+6.3%	-4.4%	-4.7%	+5.5%	+24.4%	+22.5%
Apr 23	JP Morgan	Initiates	Overweight	$31	$18.87	$18.99	+0.6%	+0.7%	-3.8%	-4.1%	+6.3%	+25.3%
Apr 22	Barclays	Initiates	Overweight	$40	$17.00	$17.65	+3.8%	+11.0%	+11.8%	+6.8%	+6.5%	+17.9%
Apr 21	UBS	Initiates	Buy	$45	$18.60	$18.05	-3.0%	-8.6%	+1.5%	+2.2%	-2.4%	-2.7%

Data updated apr 27, 2026 5:29am · Source: massive.com